Aspirin use and risk of colorectal cancer according to BRAF mutation status
about
Aspirin and Colorectal Cancer Prevention and Treatment: Is It for Everyone?Can Aspirin and Cancer Prevention be Ageless Companions?Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progressionEpidemiology of colorectal cancerERK2-Dependent Phosphorylation of CSN6 Is Critical in Colorectal Cancer DevelopmentMolecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.Genomic Profiling in Gastrointestinal Cancer: Are We Ready To Use These Data to Make Treatment Decisions?Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD)Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention.Antagonism of sorafenib and regorafenib actions by platelet factors in hepatocellular carcinoma cell lines.Biomarker correlation network in colorectal carcinoma by tumor anatomic location.Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions.Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis.Measures of adiposity are associated with increased risk of peptic ulcer.Clinical application of genetics in management of colorectal cancer.Proceedings of the second international molecular pathological epidemiology (MPE) meetingAlcohol, one-carbon nutrient intake, and risk of colorectal cancer according to tumor methylation level of IGF2 differentially methylated region.Aspirin and COX-2 inhibitor use in patients with stage III colon cancerThe role of aspirin in the prevention of cardiovascular disease.Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma.Association of Nonsteroidal Anti-Inflammatory Drugs with Colorectal Cancer by Subgroups in the VITamins and Lifestyle (VITAL) StudySessile serrated polyps: detection, eradication, and prevention of the evil twinNonsteroidal Anti-Inflammatory Drug and Aspirin Use in Relation to Lung Cancer Risk among Postmenopausal Women.The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis.Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer.MicroRNA MIR21 and T Cells in Colorectal Cancer.Integration of molecular pathology, epidemiology and social science for global precision medicine.Population-wide Impact of Long-term Use of Aspirin and the Risk for CancerPrediagnosis aspirin use and outcomes in a prospective cohort of esophageal cancer patients.Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin.Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern.Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancerAspirin and colorectal cancer: back to the future.The role of antioxidants and pro-oxidants in colon cancer.Mapping sites of aspirin-induced acetylations in live cells by quantitative acid-cleavable activity-based protein profiling (QA-ABPP).The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies.Introducing biomarker panel in esophageal, gastric, and colon cancers; a proteomic approach.Consumption of Red/Processed Meat and Colorectal Carcinoma: Possible Mechanisms Underlying the Significant Association.Drug repurposing in oncology--patient and health systems opportunities.Targeting BRAF aberrations in advanced colorectal carcinoma: from bench to bedside.
P2860
Q26749127-3D41D7E0-1DE6-45F4-965C-F9C7AF8ABCB3Q26827455-FE271C9C-4049-4035-8526-B0C5F0D3983BQ26852716-B310CC7C-ACBE-480F-BDB5-0621BFCBFEBCQ28067871-56F30C48-74F2-426B-BA79-355F3A6258E4Q28115416-66B207A8-1593-4A71-AB3C-83716C146884Q30244608-BDA26DF4-8630-430F-8796-1D0F8983A9D6Q31012680-2D6AE23E-E8EB-4678-B33F-327575D743EAQ33648694-AC9FBE49-5D4C-4633-A81D-38CDF22E8D64Q33661094-6B3AC000-E27E-41B9-B45D-0193FEB30288Q33684043-6A33A978-77FB-4599-BE2F-CD19055045F3Q33808553-787EE278-88FD-4E58-B4BC-07B86615F76FQ34016833-82889794-E52B-4554-9A79-D12CEAA0C7DFQ34169734-B73E08C3-01BB-4108-8372-680556D520FFQ34224965-9AD2E81F-116F-4F1D-980B-C0BFE51D2609Q34378719-A0EBD047-D803-4FA0-A5D4-4EDABCC42307Q34475686-CEE9B0F6-415E-4739-B491-473B02C655B5Q34511282-FF946424-B988-4A3A-9A55-B425AA2B0DA2Q34736589-20E83C0B-6DE3-4CD8-BDF2-AA26CB23873FQ35049359-FAD6F736-3B7D-4B64-86E8-C95D8480A9F6Q35137525-897167E9-25BA-4455-A5B8-BB56F20E6D14Q35251591-42C1D6DE-4480-42A4-90FA-93FA3AD1AEBEQ35593741-1AB17090-BA30-47DE-87AC-474AFF18E896Q36081562-95B8DCFD-55F9-47B3-AF5E-AE392A28826FQ36261529-9AB9D36E-3E4D-4158-94DF-5E81926ACD36Q36287410-66107DB4-DD5F-4EFA-AC16-69837A24143CQ36436728-590B72F6-917E-4BB2-BAF9-A28F60D42060Q36463854-5C931AE5-AEE1-4C78-875D-101C5E5B34F1Q36989392-09C51B75-030D-4277-B163-CDEC7AC445BEQ37361447-77431ED0-0C7B-4071-A1D4-EC4F33EA9CC1Q37413259-E3F64024-5E9C-4749-8D4A-8E6F6A620931Q37525272-702E6B5B-006C-42F0-A6DF-3E9B693E77BFQ37578728-9023BE50-B798-4E2D-850C-4B4565F3DDC2Q37626475-F6C74D00-E967-4793-97C9-7C1EABEAB6D3Q37640128-FCF254E3-A260-4216-81D4-F756080CD32BQ37736362-E42E5D0D-9B81-457D-81C9-ADDEED41790BQ38183889-90D2AC07-786A-42A3-AAD3-CD3A5E7CD5A1Q38316610-F0B1F3CD-8D3F-4FC5-8821-6E0202A5D55CQ38409303-88DC7F8E-D906-4CAA-9A1B-41639C59F4A0Q38611707-B03AB39D-BAF2-4FF4-84A0-F242267805F5Q38652294-E3A8418F-F738-470A-8D37-BF289859F6D4
P2860
Aspirin use and risk of colorectal cancer according to BRAF mutation status
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aspirin use and risk of colorectal cancer according to BRAF mutation status
@en
Aspirin use and risk of colorectal cancer according to BRAF mutation status.
@nl
type
label
Aspirin use and risk of colorectal cancer according to BRAF mutation status
@en
Aspirin use and risk of colorectal cancer according to BRAF mutation status.
@nl
prefLabel
Aspirin use and risk of colorectal cancer according to BRAF mutation status
@en
Aspirin use and risk of colorectal cancer according to BRAF mutation status.
@nl
P2093
P2860
P50
P356
P1476
Aspirin use and risk of colorectal cancer according to BRAF mutation status
@en
P2093
Andrew T Chan
Aya Kuchiba
Donna Spiegelman
Edward Giovannucci
Eunyoung Cho
Mai Yamauchi
Molin Wang
Paul Lochhead
Reiko Nishihara
Seungyoun Jung
P2860
P304
P356
10.1001/JAMA.2013.6599
P407
P577
2013-06-01T00:00:00Z